Phase II Study of Ovulation in Obese Women

Conditions: Pregnancy Prevention Interventions: Drug: Levonorgestrel 0.15 milligram; Drug: Meloxicam 15 milligram; Other: calcium carbonate 750 milligram Sponsors: InnovaGyn, Inc.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials